The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
Official Title: A Randomized, Double-blind, Multi-centre, Placebo-controlled, Parallel-arm Phase 2 Trial to Assess Safety, Efficacy and Pharmacokinetics of CD11301 0.03% and 0.06% Gel in the Treatment of Cutaneous T-Cell Lymphoma (CTCL), Stages IA, IB and IIA
Study ID: NCT03292406
Brief Summary: To assess the efficacy, safety and pharmacokinetics in participants treated with CD11301 gel vs. placebo for early stage CTCL (IA, IB, or IIA).
Detailed Description: To assess the efficacy and safety of two concentrations (0.03% and 0.06%) of CD11301 gel in the treatment of early stage CTCL (stage IA, IB, or IIA) versus placebo.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Galderma Investigational Site, Orange, California, United States
Galderma Investigational Site, Palo Alto, California, United States
Galderma Investigational Site, Farmington, Connecticut, United States
Galderma Investigational Site, Chicago, Illinois, United States
Galderma Investigational Site, Boston, Massachusetts, United States
Galderma Investigational Site, Durham, North Carolina, United States
Galderma Investigational Site, Philadelphia, Pennsylvania, United States
Galderma Investigational Site, Philadelphia, Pennsylvania, United States
Galderma Investigational Site, Pittsburgh, Pennsylvania, United States
Galderma Investigational Site, Dallas, Texas, United States
Galderma Investigational Site, Houston, Texas, United States
Galderma Investigational Site, Pierre-Bénite, Auvergne-Rhône-Alpes, France
Galderma Investigational Site, Nantes, Pays De La Loire, France
Galderma Investigational Site, Paris, Île-de-France, France
Galderma Investigational Site, Mannheim, Baden-Württemberg, Germany
Galderma Investigational Site, Wurzburg, Bavaria, Germany
Galderma Investigational Site, Krefeld, North Rhine-Westphalia, Germany
Galderma Investigational Site, Minden, North Rhine-Westphalia, Germany
Galderma Investigational Site, Münster, North Rhine-Westphalia, Germany
Galderma Investigational Site, Kiel, Schleswig-Holstein, Germany
Galderma Investigational Site, Berlin, , Germany
Name: Galderma R&D
Affiliation: Galderma R&D
Role: STUDY_DIRECTOR